IMCEPSYN Trademark

Trademark Overview

On Wednesday, December 17, 2014, a trademark application was filed for IMCEPSYN with the United States Patent and Trademark Office. The USPTO has given the IMCEPSYN trademark a serial number of 86483307. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 10, 2023. This trademark is owned by AstraZeneca AB. The IMCEPSYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
imcepsyn

General Information

Serial Number86483307
Word MarkIMCEPSYN
Filing DateWednesday, December 17, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 10, 2023
Registration Number5005806
Registration DateTuesday, July 26, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, February 10, 2023CANCELLED SEC. 8 (6-YR)
Monday, July 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 26, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, June 22, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, April 25, 2016NOTICE OF ALLOWANCE CANCELLED
Sunday, June 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 25, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 23, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 21, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 21, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 14, 2015ASSIGNED TO LIE
Thursday, August 27, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 31, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2015NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2015NON-FINAL ACTION WRITTEN
Friday, March 27, 2015ASSIGNED TO EXAMINER
Saturday, December 20, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 20, 2014NEW APPLICATION ENTERED

Related Keywords

imcepsyn diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal